Skip to main content

Corporate insider profile

Daniel M Schmitt Insider Trades

Daniel M Schmitt has reported 1 open-market purchase on SEC Form 4 and is a net buyer of $50,000 across 1 company. The most recent open-market transaction was reported on Oct 28, 2026. Source: SEC Form 4 filings.

Latest reported as President, CEO and Director of ACTUATE THERAPEUTICS, INC. (ACTU).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
1
Reported companies
1
Net open-market value
$50,000
Latest transaction
Oct 28, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 28, 2026ACTUATE THERAPEUTICS, INC. (ACTU)President, CEO and DirectorOpen Market Purchase140,844$0.36$50,000

Common questions

Daniel M Schmitt insider trading FAQ

Is Daniel M Schmitt buying or selling stock?
Across all SEC Form 4 open-market filings on record, Daniel M Schmitt is a net buyer of $50,000, with 1 open-market purchase reported. The latest transaction was reported on Oct 28, 2026.
Which companies does Daniel M Schmitt report insider trades for?
Daniel M Schmitt has reported open-market trades in ACTUATE THERAPEUTICS, INC. (ACTU). The latest SEC-reported relationship is President, CEO and Director of ACTUATE THERAPEUTICS, INC. (ACTU).
Where does Daniel M Schmitt's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1318470, and refreshes this page daily.